-
Third-Ever Post-Grant Review Decision Invalidates Patent Under § 101
August 9, 2016 -
Track One: USPTO’s Prioritized Patent Examination Program
August 1, 2016 -
USPTO Launches "Patents 4 Patients": A Cancer Immunotherapy Program
July 22, 2016 -
USPTO Adds New Pilot Initiative That Could Help Move Pending Cases Through More Quickly – Combines Features of Pre-Appeal Conference & After-Final 2.0 Program
July 12, 2016 -
BRI is Permissible Standard in IPR; USPTO Decisions to Institute IPR May Not Be Appealed
June 20, 2016
How can we help you?
Contact us at the MMV IP Law office nearest to you or submit a inquiry online.